Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 61 - 70 of 100

Selected Filters:
1 May 2022

Stakeholder conversations to inform delivery of new HIV prevention methods in Zimbabwe

Little is known about what is needed for health care providers to ensure adequate counseling on method choice, referral mechanisms, and supportive follow-up with regards to multiple biomedical HIV prevention methods. The goal of these conversations with stakeholders in Zimbabwe was to gain input on implementation considerations from provider and potential end-user perspectives, as well…

Document
15 February 2022

MTN-034 REACH

Archived from the MTN website before it was taken down. Archived MTN-034 news page also available. Primary Objectives To compare the safety profiles of FTC/TDF oral tablet administered daily and dapivirine (25 mg) vaginal matrix ring inserted once every 4 weeks during the first 24 weeks of use of each study product in an adolescent…

Research

1 August 2021

Dual Prevention Pill: A Summary of Insights and Recommendations on the uptake of the combined PrEP and Oral Contraceptive pill by women of reproductive age in SA and Zimbabwe”

Slide presentation with recommendations on increasing uptake of a combined oral PrEP and oral contraceptive pill, including specific suggestions for South Africa and Zimbabwe.

Community/Advocacy, Demand Creation/Marketing, Research

Document
1 August 2021

Dual Prevention Pill: The Eureka Workshops Recommendations and Solutions

Slide presentation focused on how best to inform women about the dual prevention pill and instilling confidence that they could take a pill every day.

Community/Advocacy, Research

Document
1 August 2021

Service Delivery Strategy for the Dual Prevention Pill

Slide presentation providing recommendations for a phased implementation of the dual prevention pill in Kenya, South Africa and Zimbabwe.

Community/Advocacy, Service Delivery

Document
1 May 2021

Health Care Provider Training for New HIV Prevention Products

This presentation was developed to inform the development of training curricula for new biomedical HIV prevention products. It provides summary insights from an analysis of provider training systems in Kenya, South Africa, and Zimbabwe developed for introduction of the dapivirine vaginal ring in 2020 – 2021.

Service Delivery

Document
1 March 2021

Test-And-Prevent Analysis: Evaluation of a Pilot Program Linking Clients With Negative HIV Test Results to Pre-exposure Prophylaxis in Zimbabwe

A journal article appearing in Global Health: Science and Practice supporiting clinics offering PrEP to clients receiving negative results to HIV tests.

Research, Testing

Document
1 February 2021

MTN-025

Archived from the MTN website before it was taken down. Primary Objectives Characterize the safety profile associated with the open-label use of the dapivirine (25 mg) vaginal matrix ring (VR) in women Characterize adherence to the open-label use of the dapivirine VR (25 mg) in women Study Summary MTN-025, the HIV Open-label Prevention Extension (HOPE)…

Research

1 November 2020

What is CHOICE?

An overview of the CHOICE project

Demand Creation/Marketing, Research, Service Delivery

Document
1 November 2020

Creating Demand for PrEP Among Adolescent Girls & Young Women

Slide-deck Review of HIV, PrEP and Contraceptive Focused Projects in Sub-Saharan Africa

Demand Creation/Marketing

Document